Loading...
XCNQ
MYTC
, Last price  
CAD
Name

MyndTec Inc

Chart & performance

D1W1MN
XCNQ:MYTC chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
111k
-18.85%
162,634605,567255,801137,312111,434
Net income
-1m
L-27.62%
-1,809,010-3,335,260-2,247,105-1,723,330-1,247,407
CFO
-920k
L-5.85%
-1,395,137-1,435,634-2,343,697-976,907-919,802

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MyndTec Inc. is a medical technology firm dedicated to the research, development, and distribution of therapeutic solutions. Its primary focus is on individuals in Canada and the United States who experience paralysis resulting from stroke or spinal cord injuries. At the heart of its offerings is MyndMove, a flagship product that employs a non-invasive functional electrical stimulation (FES) approach. This intervention leverages the brain's neuroplasticity to foster the creation of new motor and sensory neural pathways, enabling patients to regain voluntary movement and enhance their independence in daily activities. It also empowers trained therapists to assist patients in improving conscious control over their limbs. Beyond therapies, MyndTec supplies its MyndMove and MyndSearch devices to clinics and research institutions, alongside selling essential treatment consumables. The company serves hospitals through a combination of direct sales efforts and an established network of distributors. Established in 2008, the company initially operated as Simple Systems Inc. before rebranding as MyndTec Inc. in April 2013. Its corporate headquarters are located in Mississauga, Canada.
IPO date
Feb 24, 2022
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT